Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis

Journal of Clinical Pharmacology

Volumn 45, Issue 8, 2005, Pages 872-877

  Donnenberg, Vera S ^a   Donnenberg, Albert D ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Cancer stem cell; Chemotherapy; Multiple drug resistance; Oncogenesis

Indexed keywords

ANTINEOPLASTIC AGENT; BIRICODAR; CARRIER PROTEIN; CYCLOSPORIN; DOXORUBICIN; ELACRIDAR; ETOPOSIDE; LIPOSOME; MULTIDRUG RESISTANCE PROTEIN; PROTEIN INHIBITOR; QUINIDINE; VALSPODAR; VERAPAMIL; VINBLASTINE; VINCRISTINE; ZOSUQUIDAR;

AREA UNDER THE CURVE; CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER STEM CELL HYPOTHESIS; CARCINOGENESIS; CELL HETEROGENEITY; CELL PROTECTION; CELL TRANSFORMATION; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG TUMOR LEVEL; HEMATOLOGIC MALIGNANCY; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; REVIEW; SIDE EFFECT; STEM CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; P-GLYCOPROTEIN; P-GLYCOPROTEINS; TUMOR STEM CELLS;

EID: 23044514578     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270005276905     Document Type: Review

References (36)

1. Kessel D, Botterill V, Wodinsky I. Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response. Cancer Res. 1968;28:938-941.
2. Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. 1970;30:1174-1184.
3. Ling V, Thompson LH. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol. 1974;83(1):103-116.
4. Roninson IB, Abelson HT, Housman DE, Howell N, Varshavsky A. Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells. Nature. 1984;309:626-628.
5. Gros P, Croop J, Roninson I, Varshavsky A, Housman DE. Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells. Proc Natl Acad Sci U S A. 1986;83:337-341.
6. Roninson IB, Chin JE, Choi KG, et al. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A. 1986;83:4538-4542.
7. Gros P, Ben Neriah YB, Croop JM, Housman DE. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 1986;323:728-731.
8. Twentyman PR, Fox NE, Bleehen NM. Drug resistance in human lung cancer cell lines: cross-resistance studies and effects of the calcium transport blocker, verapamil. Int J Radiat Oncol Biol Phys. 1986;12:1355-1358.
9. Harker WG, Slade DL, Dalton WS, Meltzer PS, Trent JM. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. Cancer Res. 1989;49:4542-4549.
10. Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A. 1998;95:15665-15670.
11. Baines P, Visser JW. Analysis and separation of murine bone marrow stem cells by H33342 fluorescence-activated cell sorting. Exp Hematol. 1983;11:701-708.
12. Mulder AH, Visser JW. Separation and functional analysis of bone marrow cells separated by rhodamine-123 fluorescence. Exp Hematol. 1987;15:99-104.
13. Udomsakdi C, Eaves CJ, Sutherland HJ, Lansdorp PM. Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. Exp Hematol. 1991;19:338-342.
14. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797-1806.
15. Bunting KD, Zhou S, Lu T, Sorrentino BP. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood. 2000;96:902-909.
16. Zhou S, Morris JJ, Barnes Y, Lan L, Schuetz JD, Sorrentino BP. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci U S A. 2002;99:12339-12344.
17. Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001;7:1028-1034.
18. Giangreco A, Shen H, Reynolds SD, Stripp BR. Molecular phenotype of airway side population cells. Am J Physiol Lung Cell Mol Physiol. 2004;286:L624-L630.
19. Merry S, Courtney ER, Fetherston CA, Kaye SB, Freshney RI. Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamil. Br J Cancer. 1987;56:401-405.
20. Fojo A, Hamilton TC, Young RC, Ozols RF. Multidrug resistance in ovarian cancer. Cancer. 1987;60(suppl 8):2075-2080.
21. Rustum YM, Radel S, Campbell J, Mayhew E. Approaches to overcome in vivo anti-cancer drug resistance. Prog Clin Biol Res. 1986; 223:187-202.
22. Dey S, Ramachandra M, Pastan I, Gottesman MM, Ambudkar SV. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc Natl Acad Sci U S A. 1997;94:10594-10599.
23. Lum BL, Fisher GA, Brophy NA, et al. Clinical trials of modulation of multidrug resistance: pharmacokinetic and pharmacodynamic considerations. Cancer. 72(suppl 11):3502-3514.
24. Chen CC, Meadows B, Regis J, et al. Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi. Clin Cancer Res. 1997;3:545-552.
25. Carrion C, de Madariaga MA, Domingo JC. In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34(+) leukemic cells. Life Sci. 2004;75:313-328.
26. Tan B, Piwnica-Worms D, Ratner L. Multidrug resistance transporters and modulation. Curr Opin Oncol. 2000;12:450-458.
27. Fiala S. The cancer cell as a stem cell unable to differentiate: a theory of carcinogenesis. Neoplasma. 1968;15:607-622.
28. Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science. 1977;197:461-463.
29. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-111.
30. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science. 1988;241: 58-62.
31. Volm M. Multidrug resistance and its reversal. Anticancer Res. 1998;18:2905-2917.
32. Shoemaker RH, Curt GA, Carney DN. Evidence for multidrug-resistant cells in human tumor cell populations. Cancer Treat Rep. 1983;67:883-888.
33. Leonard GD, Fojo T, Bates SE. The role of ABC transporters in clinical practice. Oncologist. 2003;8:411-424.
34. Appelbaum FR, Fisher LD, Thomas ED. Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up. Blood. 1988;72:179-184.
35. Burnett AK. Annotation: current controversies-which patients with acute myeloid leukaemia should receive a bone marrow transplantation? An adult treater's view. Br J Haematol. 2002;118:357-364.
36. Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med. 1979;300:1068-1073.